SKI Market

Indian Indices

Sensex

82,180.47 -1,065.71
( -1.28%)

Global Indices

Nasdaq

49,380.33 -83.12
(-0.17%)

Dow Jones

6,961.01 -4.46
(-0.06%)

Hang Seng

53,052.63 -530.94
(-0.99%)

Nikkei 225

10,111.70 -83.65
(-0.82%)

Forex

USD-INR

90.54 0.22
(0.24%)

EUR-INR

105.01 0.03
(0.03%)

GBP-INR

121.08 -0.01
(-0.01%)

JPY-INR

0.57 0.00
(0.52%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

85.91

401540.7

EPS(TTM)

Face Value()

Div & Yield %

19.48

0.96

Back

Sun Pharmaceutical Industries consolidated net profit rises 2.56% in the September 2025 quarter

Nov 05,2025

Net profit of Sun Pharmaceutical Industries rose 2.56% to Rs 3117.95 crore in the quarter ended September 2025 as against Rs 3040.16 crore during the previous quarter ended September 2024. Sales rose 8.60% to Rs 14405.22 crore in the quarter ended September 2025 as against Rs 13264.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	14405.22	13264.22	9
OPM %	31.43	29.70	-
PBDT	4897.11	4223.79	16
PBT	4167.61	3597.88	16
NP	3117.95	3040.16	3

82,180.47 -1,065.71 ( -1.28%)

49,380.33 -83.12 (-0.17%)

6,961.01 -4.46 (-0.06%)

53,052.63 -530.94 (-0.99%)

10,111.70 -83.65 (-0.82%)

90.54 0.22 (0.24%)

105.01 0.03 (0.03%)

121.08 -0.01 (-0.01%)

0.57 0.00 (0.52%)